Christopher Sullivan

Christopher Sullivan

Director of Finance/CFO at AVALO THERAPEUTICS, INC.

Net worth: 611 667 $ as of 2026-09-29

42 year
Commercial Services
Health Technology
Consumer Services

Profile

Christopher Sullivan is currently Chief Financial Officer at Avalo Therapeutics, Inc. since 2022.
Formerly, Mr. Sullivan was Controller at Sucampo Pharmaceuticals LLC from 2017 to 2018, Controller at CapForce, Inc. from 2015 to 2017, and Senior Manager at Ernst & Young LLP.
Mr. Sullivan completed undergraduate studies at the University of Maryland.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-09-15 39,900 ( 0.07% ) 611 667 $ 2026-09-29

Christopher Sullivan active positions

CompaniesPositionStart
AVALO THERAPEUTICS, INC. Director of Finance/CFO 2022-02-13

Former positions of Christopher Sullivan

CompaniesPositionEnd
SUCAMPO PHARMACEUTICALS, INC. Comptroller/Controller/Auditor 2018-03-31
CAPFORCE INC. Comptroller/Controller/Auditor 2017-07-31
Corporate Officer/Principal -
See the detail of Christopher Sullivan's experience

Education of Christopher Sullivan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

56

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Commercial Services

Commercial Services

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Christopher Sullivan